SEATTLE, WA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)FRED HUTCHINSON CANCER RESEARCH CENTER, founded in 1971, is a major nonprofit that reported $696.8M in total revenue in fiscal year 2021. Revenue fell 26% from the prior year — a significant decline worth monitoring. Expenses of $610.3M left a modest 12% surplus.
OUR RESEARCHERS ARE PUSHING THE LIMITS OF HUMAN KNOWLEDGE, FROM FOUNDATIONAL BIOLOGY TO POPULATION-LEVEL HEALTH. THROUGH FEARLESS SCIENCE, COLLABORATION ACROSS DISCIPLINES, AND UNSHAKABLE FOCUS, WE'RE LEADING THE WAY TO A WORLD FREE OF CANCER AND RELATED DISEASES.
VACCINE AND INFECTIOUS DISEASE DIVISION (VIDD): VIDD INTEGRATES THE LATEST IN COMPUTATIONAL, LABORATORY AND CLINICAL RESEARCH METHODS TO ADVANCE THE UNDERSTANDING OF MICROBIAL PATHOGENESIS AND...
VACCINE AND INFECTIOUS DISEASE DIVISION (VIDD): VIDD INTEGRATES THE LATEST IN COMPUTATIONAL, LABORATORY AND CLINICAL RESEARCH METHODS TO ADVANCE THE UNDERSTANDING OF MICROBIAL PATHOGENESIS AND INFECTIOUS DISEASE PROCESSES. VIDD RESEARCHERS PARTNER WITH SCIENTISTS AT LABORATORY, CLINICAL AND FIELD SITES IN THE AMERICAS, AFRICA, ASIA AND EUROPE. THE DIVISION HAS SPECIFIC INITIATIVES IN UGANDA, CHINA AND THE REPUBLIC OF SOUTH AFRICA TO ADVANCE THE UNDERSTANDING OF INFECTION-RELATED CANCERS AND INFECTIOUS DISEASES THAT AFFECT HIGH-RISK POPULATIONS IN THESE REGIONS. VIDD SCIENTISTS AROUND THE WORLD, INCLUDING CLINICIANS, CLINICAL TRIAL SPECIALISTS, STATISTICIANS, COMPUTATIONAL BIOLOGISTS AND BASIC SCIENTISTS, TAKE PRIDE IN THEIR COLLABORATIVE EFFORTS TO PREDICT, DETECT, TREAT AND PREVENT INFECTIOUS DISEASES IN HUMANS, INCLUDING KNOWN AND EMERGING INFECTIONS OF MAJOR GLOBAL HEALTH IMPORTANCE, SUCH AS CORONAVIRUS, AND CANCER-RELATED INFECTIOUS DISEASES.
CLINICAL RESEARCH DIVISION:THE CLINICAL RESEARCH DIVISION CONDUCTS LABORATORY AND PATIENT-ORIENTED RESEARCH TO BETTER UNDERSTAND THE MECHANISMS THAT DRIVE CANCER AND OTHER HUMAN DISEASES. INTEGRATING...
CLINICAL RESEARCH DIVISION:THE CLINICAL RESEARCH DIVISION CONDUCTS LABORATORY AND PATIENT-ORIENTED RESEARCH TO BETTER UNDERSTAND THE MECHANISMS THAT DRIVE CANCER AND OTHER HUMAN DISEASES. INTEGRATING A VARIETY OF DISCIPLINES, OUR CLINICAL RESEARCHERS ARE CONTINUALLY DEVELOPING NEW THERAPEUTIC APPROACHES AND LEADING CLINICAL TRIALS THAT HELP MOVE DISCOVERIES FROM LABORATORY TO PATIENT. OUR PIONEERING RESEARCH HAS SAVED HUNDREDS OF THOUSANDS OF LIVES.
PUBLIC HEALTH SCIENCES DIVISION:THE PUBLIC HEALTH SCIENCES DIVISION IDENTIFIES STRATEGIES THAT WOULD ULTIMATELY REDUCE THE INCIDENCE OF AND MORTALITY FROM CANCER AND OTHER DISEASES. USING LARGE...
PUBLIC HEALTH SCIENCES DIVISION:THE PUBLIC HEALTH SCIENCES DIVISION IDENTIFIES STRATEGIES THAT WOULD ULTIMATELY REDUCE THE INCIDENCE OF AND MORTALITY FROM CANCER AND OTHER DISEASES. USING LARGE POPULATIONS AS THEIR "LABORATORY," OUR PUBLIC-HEALTH RESEARCHERS LOOK FOR LINKS BETWEEN CANCER AND ITS POSSIBLE TRIGGERS, FROM DIET AND LIFESTYLE TO ENVIRONMENTAL AND GENETIC FACTORS. IDENTIFYING SUCH CANCER CAUSES CAN LEAD TO BETTER CANCER-DETECTION METHODS AND NEW WAYS TO HELP PEOPLE ADOPT HEALTHIER LIFESTYLES TO MINIMIZE OR AVOID THEIR RISK OF GETTING THE DISEASE IN THE FIRST PLACE. OUR STATISTICAL, COMPUTATIONAL, EPIDEMIOLOGICAL, TRANSLATIONAL AND PREVENTION PROJECTS INCLUDE STUDIES AROUND THE WORLD.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2021 | 2020 | Change | |
|---|---|---|---|
| Revenue | $696,845,474 | $943,352,737 | -0.3% |
| Expenses | $610,254,707 | $829,721,537 | -0.3% |
| Net Income | $86,590,767 | $113,631,200 | -0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| KATHY SURACE-SMITH | CHAIR | 7.70 |
Officer
Director
|
$0 | $0 | $0 |
| LEIGH MORGAN | VICE CHAIR | 6.40 |
Officer
Director
|
$0 | $0 | $0 |
| SEAN BOYLE | TREASURER | 4.90 |
Officer
Director
|
$0 | $0 | $0 |
| RICHARD W ANDERSON | SECRETARY | 3.30 |
Officer
Director
|
$0 | $0 | $0 |
| CARL BEHNKE | TRUSTEE | 2.20 |
Director
|
$0 | $0 | $0 |
| MICHAEL CLAYVILLE | TRUSTEE | 1.90 |
Director
|
$0 | $0 | $0 |
| HOLLIS S DILLON | TRUSTEE | 2.90 |
Director
|
$0 | $0 | $0 |
| MARK FLEISCHAUER | TRUSTEE | 1.90 |
Director
|
$0 | $0 | $0 |
| THERESA GILLESPIE | TRUSTEE | 1.90 |
Director
|
$0 | $0 | $0 |
| STEPHEN M GRAHAM | TRUSTEE | 3.10 |
Director
|
$0 | $0 | $0 |
| CHRISTINE GREGOIRE | TRUSTEE | 2.90 |
Director
|
$0 | $0 | $0 |
| ROBERT HERBOLD | TRUSTEE | 1.60 |
Director
|
$0 | $0 | $0 |
| ALLAN JONES | TRUSTEE | 1.90 |
Director
|
$0 | $0 | $0 |
| PHILIP KENT | TRUSTEE | 2.10 |
Director
|
$0 | $0 | $0 |
| CONNIE KRAVAS | TRUSTEE | 2.40 |
Director
|
$0 | $0 | $0 |
| MATTHEW MCILWAIN | TRUSTEE | 4.60 |
Director
|
$0 | $0 | $0 |
| NORMAN METCALFE | TRUSTEE | 2.20 |
Director
|
$0 | $0 | $0 |
| SATYA NADELLA | TRUSTEE | 1.30 |
Director
|
$0 | $0 | $0 |
| PAUL W REED | TRUSTEE | 3.00 |
Director
|
$0 | $0 | $0 |
| BRIAN ROBERTS | TRUSTEE | 1.90 |
Director
|
$0 | $0 | $0 |
| CORAZON SANDERS | TRUSTEE | 2.40 |
Director
|
$0 | $0 | $0 |
| PETE SHIMER | TRUSTEE | 1.90 |
Director
|
$0 | $0 | $0 |
| BRYAN WHITE | TRUSTEE | 3.20 |
Director
|
$0 | $0 | $0 |
| THOMAS JAMES LYNCH JR | PRESIDENT & DIRECTOR | 40.00 |
Officer
|
$1,702,109 | $66,608 | $1,768,717 |
| NANCY E DAVIDSON | SR. VP & DIRECTOR, CRD | 8.40 |
Officer
|
$1,266,466 | $47,218 | $1,313,684 |
| ERIC C HOLLAND | SR VP & DIR, HUMAN BIOLOGY | 40.00 |
Officer
|
$776,770 | $53,518 | $830,288 |
| DAVID HARLAN BROWDY | VP & CHIEF FINANCIAL OFFICER | 40.00 |
Officer
|
$853,047 | $61,264 | $914,311 |
| BRUCE E CLURMAN | EXEC VP & DEPUTY DIR, FHCRC | 40.00 |
Officer
|
$767,846 | $56,974 | $824,820 |
| NICOLE C ROBINSON | VP & CHIEF OPERATING OFFICER | 40.00 |
Officer
|
$849,608 | $53,518 | $903,126 |
| FREDERICK R APPELBAUM | EXEC VP & DEPUTY DIRECTOR | 40.00 |
Officer
|
$758,585 | $55,623 | $814,208 |
| STEVEN HAYDON | VP, GENERAL COUNSEL | 40.00 |
Officer
|
$585,496 | $56,827 | $642,323 |
| GEOFFREY R HILL | SR VP & DIR BGI | 40.00 |
Officer
|
$450,843 | $55,890 | $506,733 |
| MARGARET JULIANA MCELRATH | SR VP & DIRECTOR - VIDD | 40.00 |
Officer
|
$491,059 | $46,432 | $537,491 |
| KELLY O'BRIEN | VICE PRESIDENT, PHILANTHROPY | 40.00 |
Officer
|
$515,402 | $56,339 | $571,741 |
| JODI LORRAINE BURKE | VP HUMAN RESOURCES | 40.00 |
Officer
|
$464,479 | $51,497 | $515,976 |
| MARION S DORER | VP, INTERDISCIPLINARY SCI ADM | 40.00 |
Officer
|
$478,101 | $47,124 | $525,225 |
| CHRISTOPHER LI | VP, FACULTY AFFAIR & DIVERSITY | 40.00 |
Officer
|
$370,933 | $59,646 | $430,579 |
| GARNET L ANDERSON | SR VP & DIR, PHS | 40.00 |
Officer
|
$412,815 | $47,100 | $459,915 |
| JENNIFER E GRIFFITH | VP GOV'T & COMMUNITY RELATIONS | 40.00 |
Officer
|
$368,396 | $46,834 | $415,230 |
| CHRIS BUNDESMANN | CORPORATE CONTROLLER | 40.00 |
Officer
|
$269,599 | $43,862 | $313,461 |
| JONATHAN A COOPER | SR VP & DIR, BASIC SCIENCES | 40.00 |
Officer
|
$262,229 | $43,876 | $306,105 |
| KATHY L ALEXION | VP & CHIEF INFORMATION OFFICER | 40.00 |
Officer
|
$321,053 | $35,200 | $356,253 |
| ELIZABETH BOYD | VP, RES ADM & FACULTY AFFAIRS | 40.00 |
Officer
|
$276,810 | $42,625 | $319,435 |
| PAUL M BUCKLEY | VP & CHIEF DIVERS/INCL OFFICER | 40.00 |
Officer
|
$293,316 | $44,681 | $337,997 |
| HERBERT L BONE III | CORPORATE TREASURER | 40.00 |
Officer
|
$231,853 | $44,129 | $275,982 |
| VAL RIE J SMITH | ASSISTANT TO THE BOARD OF TRUSTEES | 40.00 |
Officer
|
$117,182 | $18,078 | $135,260 |
| SUSAN BIGGINS | SR VP & DIR, BASIC SCIENCES | 13.20 |
Officer
|
$112,819 | $0 | $112,819 |
| SCOTT N RUSCH | VP, FACILITIES & OPERATIONS | 5.00 |
Officer
|
$3,085 | $0 | $3,085 |
| KELLY PATRICK | VP, CHIEF INFORMATION OFFICER | 40.00 |
Officer
|
$0 | $0 | $0 |
| STEVE STADUM | SPEC ADVISOR | 40.00 |
Highest
|
$1,132,208 | $56,974 | $1,189,182 |
| PETER S NELSON | FULL PROFESSOR | 40.00 |
Highest
|
$449,036 | $60,222 | $509,258 |
| STEPHANIE J LEE | FULL PROFESSOR | 40.00 |
Highest
|
$390,143 | $38,001 | $428,144 |
| JERALD PATRICK RADICH | FULL PROFESSOR | 40.00 |
Highest
|
$396,440 | $59,736 | $456,176 |
| STANLEY R RIDDELL | FULL PROFESSOR | 40.00 |
Highest
|
$394,966 | $55,733 | $450,699 |
| D GARY GILLILAND | PRESIDENT & DIRECTOR EMERITUS | 5.00 |
|
$168,188 | $0 | $168,188 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2022 | $696,845,474 | $610,254,707 | No data | $86,590,767 |
| 2021 | $943,352,737 | $829,721,537 | $1,740,460,544 | $113,631,200 |
| 2020 | $630,515,570 | $645,999,059 | $1,469,345,450 | $-15,483,489 |
| 2019 | $698,140,612 | $633,715,331 | $1,321,100,570 | $64,425,281 |
| 2018 | $851,220,102 | $588,136,835 | $1,227,585,664 | $263,083,267 |
Compare FRED HUTCHINSON CANCER RESEARCH CENTER with other nonprofits in Washington and across the country.